86 results
8-K
EX-99.1
EQ
Equillium Inc
9 May 24
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
4:05pm
Current portion of deferred revenue
Total current liabilities
Other long-term liabilities
Total liabilities
Total stockholders' equity
Total
8-K
EX-99.1
m59a soxjqgb8h
25 Mar 24
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
4:05pm
8-K
EX-99.2
r9kjz6sa
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
8-K
EX-99.1
wmg16l56
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
8-K
EX-99.1
zjh8tg fs706f0pux
16 Oct 23
Regulation FD Disclosure
8:05am
8-K
EX-1.1
tdufuk4hxxtsi nu7
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
0ns7d3v
9 Aug 23
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
4:06pm
8-K
EX-99.1
xcznwz4 n3hccd6r
11 May 23
Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates
4:06pm
PRE 14A
lddvdjz7kn45 mat
31 Mar 23
Preliminary proxy
4:02pm
425
2yv xjtdpa
14 Nov 22
Business combination disclosure
4:20pm